Alnylam Pharmaceuticals
ALNY
#633
Rank
โ‚น2.666 T
Marketcap
โ‚น20,676
Share price
-5.01%
Change (1 day)
46.57%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: โ‚น2.666 Trillion

As of November 2024 Alnylam Pharmaceuticals has a market cap of โ‚น2.666 Trillion. This makes Alnylam Pharmaceuticals the world's 633th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚น2.666 T33.36%
2023โ‚น1.999 T-17.35%
2022โ‚น2.419 T60.27%
2021โ‚น1.509 T36.7%
2020โ‚น1.104 T19.85%
2019โ‚น921.38 B78.63%
2018โ‚น515.80 B-35.88%
2017โ‚น804.49 B268.48%
2016โ‚น218.33 B-58.99%
2015โ‚น532.33 B12.16%
2014โ‚น474.61 B87.44%
2013โ‚น253.21 B382.76%
2012โ‚น52.45 B184.73%
2011โ‚น18.42 B-1.54%
2010โ‚น18.70 B-45.3%
2009โ‚น34.20 B-30.52%
2008โ‚น49.22 B5.79%
2007โ‚น46.53 B32.51%
2006โ‚น35.11 B202.91%
2005โ‚น11.59 B85.84%
2004โ‚น6.23 B

End of Day market cap according to different sources

On Nov 14th, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

โ‚น2.807 Trillion
by Yahoo Finance info icon info icon
โ‚น2.807 Trillion
by CompaniesMarketCap info icon info icon
โ‚น2.807 Trillion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚น199.97 B-92.50%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.051 T 164.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น852.59 B-68.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น93.02 B-96.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.93 B-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น17.596 T 559.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น10.567 T 296.28%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น1.574 T-40.97%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel